| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202723A2 Use of anti-muscarinic agents for treating skin disorders |
| 05/08/2002 | EP1202700A1 Oil-in-water emulsion with improved stability |
| 05/08/2002 | EP0923585B1 Phosphinate based inhibitors of matrix metalloproteases |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/08/2002 | CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 05/08/2002 | CN1348439A New compounds, their preparation and use |
| 05/08/2002 | CN1348381A Treatment with small peptides to effect antifibrotic activity |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1348363A Novel pharmaceutical salt form |
| 05/08/2002 | CN1348356A Cosmetic and/or pharmaceutical preparations |
| 05/08/2002 | CN1347726A Polygonic multiflori tea |
| 05/08/2002 | CN1347724A Tendering, whitening and antiaging sun screen lotion |
| 05/08/2002 | CN1347723A Yubai hand whitening ointment |
| 05/08/2002 | CN1347722A Verruca piana eliminating medicine and its prepn |
| 05/08/2002 | CN1347721A Beriberi eliminating lotion |
| 05/08/2002 | CN1347720A Hair moistening liquid with functions of nourishing hair, restoring hair, stopping baldness and eliminating scurf |
| 05/08/2002 | CN1347719A Scar levelling ointment |
| 05/08/2002 | CN1347717A Psoriasis treating medicine and its processing method |
| 05/08/2002 | CN1347703A Leukoderma treating externally-used medicine |
| 05/08/2002 | CN1347701A Seahorse powder capsule |
| 05/08/2002 | CN1347691A Body whitening and spicing bath lotion |
| 05/08/2002 | CN1347690A Skin whitening cream |
| 05/08/2002 | CN1084207C Medicinal liquor and ointment for treating traumatic injury |
| 05/08/2002 | CN1084199C Scenting pellet |
| 05/08/2002 | CN1084198C Chinese herbal medicine bolus for treating psoriasis |
| 05/08/2002 | CN1084196C Burn ointment |
| 05/08/2002 | CN1084191C Basin bath medicated liquor for curing tinea pedis, sweaty feet and smelly feet |
| 05/07/2002 | US6384261 Treating endothelin-mediated disorders; inhibitory binding of endothilin peptides to eta and/or etb receptors; elucidating the physiological and pathophysiological roles and isolating endothelin receptors; antagonists |
| 05/07/2002 | US6384189 Compositions for stimulating TGF-β activity |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384072 Carbamyl substituted compounds with ether groups |
| 05/07/2002 | US6384025 Skin disorders; reacting retinol with chloroformate compound |
| 05/07/2002 | US6384023 Silicone gel containing salicylic acid |
| 05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
| 05/07/2002 | US6383474 Carotenoid preparation |
| 05/07/2002 | CA2216535C Protein kinase c inhibitors |
| 05/07/2002 | CA2214884C Poly(hydroxy acid)/polymer conjugates for skin applications |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034721A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2002034292A1 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist |
| 05/02/2002 | WO2002034283A2 Vegh inhibitors and their use |
| 05/02/2002 | WO2002034265A1 Use of 2-hydrazino-1,3-thiazoles as antioxidants |
| 05/02/2002 | WO2002034262A1 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 05/02/2002 | WO2002034253A1 Hair growth stimulant |
| 05/02/2002 | WO2002034236A2 Lipid formulations for target delivery |
| 05/02/2002 | WO2002034235A1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| 05/02/2002 | WO2002034233A2 Use of an association of a carotenoid and of an isoflavonoid for treating cutaneous symptoms of ageing |
| 05/02/2002 | WO2002034232A2 Use of carotenoids for treating ageing symptoms |
| 05/02/2002 | WO2002034231A2 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2002011677A3 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 05/02/2002 | WO2002002562A3 Heteropolycyclic inhibitors |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
| 05/02/2002 | WO2001094586A3 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 05/02/2002 | WO2001091774A3 Method of treating chronic ulcers |
| 05/02/2002 | WO2001091773A3 Method of stimulating hair growth |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | WO2001089450A3 Treating musculoskeletal disorders using lp85 and analogs thereof |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
| 05/02/2002 | WO2001066772A3 Heparinase iii and uses thereof |
| 05/02/2002 | WO2001064749A3 Method for preparing anti-mif antibodies |
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001062082A3 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 05/02/2002 | WO2001055210A3 Human cyr61 |
| 05/02/2002 | WO2001045688A3 Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients |
| 05/02/2002 | WO2001044264A3 Novel stromelysin inhibitors |
| 05/02/2002 | WO2001034767A3 22 human secreted proteins |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/02/2002 | US20020052504 N-((2-cyclopropoxy-5-(1H-tetrazol-1-))phenyl)methyl-2-(4 -phenyl)piperidin-3-amine and derivatives; in particular as neurokinin-1 receptor antagonists; analgesics; migraines; antiinflammatory, anxiolytic, emetic agents; antidepressants |
| 05/02/2002 | US20020052498 (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same |
| 05/02/2002 | US20020052416 Use of prostaglandin EP-3 receptor antagonists as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052397 Treatment of diseases characterized by excess Th2 cytokines and/ or an excess IgE production. |
| 05/02/2002 | US20020052387 5-Substituted 2-aryl-4-pyrimidinones |
| 05/02/2002 | US20020052386 Pyrimidine derivatives |
| 05/02/2002 | US20020052369 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 05/02/2002 | US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds |
| 05/02/2002 | US20020052350 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses |
| 05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
| 05/02/2002 | US20020052333 Therapeutic use of cis-element decoys in vivo |
| 05/02/2002 | US20020052326 Treating diabetes and related diseases in combination with one, two or more other antidiabetic agents and/or one, two or more hypolipidemic agents. |
| 05/02/2002 | US20020052323 Protease inhibitors, particularly for caspase enzyme; treating arthritis, ALS, MS, and the like. |
| 05/02/2002 | US20020052320 Sustained peptide-release formulation |